Jason Kelly, Ginkgo CEO (Kyle Grillot/Bloomberg via Getty Images)

At­ten­tion biotech his­to­ry: Gink­go pours $700M+ on just 2 ex­ecs

Gink­go CEO Ja­son Kel­ly and COO Resh­ma Shet­ty just be­came two of the most high­ly paid ex­ec­u­tives in biotech his­to­ry — sort of.

The con­tro­ver­sial syn­thet­ic bi­ol­o­gy com­pa­ny, sub­ject to near­ly a year of scruti­ny from jour­nal­ists and short-sell­ers af­ter a SPAC that val­ued it at $15 bil­lion, re­leased an an­nu­al re­port Wednes­day that in­clud­ed the an­nu­al com­pen­sa­tion for the two founder-ex­ec­u­tives: $364 mil­lion, apiece.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.